SOMPO Holdings has structured its operations into two strategic pillars: SOMPO P&C and SOMPO Wellbeing. The Wellbeing segment builds a data-driven ecosystem tackling health, senior care, and financial concerns. Through its Platform Business, technological innovations, and international alliances, SOMPO is exporting its operational expertise to scale its high-touch care model globally.

Vietnam is rapidly transforming its healthcare system through regulatory reforms, expanded geriatric care, and stronger private sector participation. Backed by government policies and rising institutional investment, the country offers growing opportunities in hospitals, long-term care, digital health, medical devices, and medical tourism, positioning itself as one of Asia's emerging healthcare investment destinations.

Geri Care’s new 100-bed facility in Coimbatore addresses India's growing need for specialized, long-term geriatric care. As the elderly population rapidly expands, the country's senior living sector is transitioning into a mainstream asset class. Despite challenges like cultural stigma and high costs, massive demand-supply gaps point toward significant, sustained market growth over the next decade.

The US senior housing sector experienced explosive growth in Q1 2026, fueled by the massive baby boomer generation turning eighty and historically low construction starts. While independent living occupancy reached milestones, assisted living pricing power accelerated sharply. This robust performance and resilient cash flows prompted major global institutional investors to aggressively rotate capital into assets.

The global exoskeleton market is experiencing massive growth, driven by aging workforces, rising injury costs, and technology maturation. Tech giants and national funds are heavily investing, viewing these devices as data gateways. Meanwhile, China is pivoting toward ultra-lightweight, affordable consumer-grade models, reshaping the international landscape through strict cost leadership, rapid patent dominance, and mass-market democratization.

As of 2026, medical aid in dying is legal in 13 states and Washington, D.C. Unlike illegal euthanasia, patients must self-administer the medication. Strict rules require terminal prognoses and verified mental competence. While advocates support it as a victory for patient autonomy, critics, particularly disability rights organizations, raise serious legal and ethical concerns regarding societal vulnerability.